Tag Archive: Uninsured

Laws Proposed to Protect Patients from Artificially High Prescription Costs

In a previous blog post, we explored “clawback” and how it affects the prices of prescriptions. In short, Pharmacy Benefit Managers (PBMs) negotiate copay prices for insurers that are often higher than the cash price paid by uninsured patients all while instituting a “gag rule” for pharmacists to forbid them from revealing the price discrepancy …

Continue reading »

LGBT Health Awareness Week 2018

The last week of March has been LGBT Health Awareness Week since 2003. We have gone over some of the barriers to health care for some of the transgender community in previous blog posts, but it remains important to bring awareness to the unique healthcare needs of lesbian, gay, bisexual, and transgender people and the …

Continue reading »

Open Enrollment by the Numbers

health insurance

Open enrollment for Affordable Care Act (ACA; aka Obamacare) coverage ended across the United States in mid-December, but the last few states ended their open enrollment period at the end of January. We wrote in November about the state of Open Enrollment, and discussed the impacts of confusion surrounding the healthcare law earlier this year. …

Continue reading »

ACA Open Enrollment

DNjFvdkXUAEz9gS

The Affordable Care Act (ACA; aka Obamacare) Health Insurance Marketplace begins its fifth Open Enrollment period today. American healthcare consumers can sign up on the federal insurance exchange at healthcare.gov or through their state marketplaces. This year, there is increased confusion and anxiety surrounding Open Enrollment due to changes (and attempted changes) made to the …

Continue reading »

What is a Clawback & How it’s Affecting Your Prescription Copays

Pharmacy

Americans may be surprised to learn that they could be paying more for their medications with their insurance copay instead of the cash price available to those without insurance. A study published last week found that Pharmacy Benefit Managers (PBMs) undermine claims that negotiated “rebates” with pharmaceutical companies are passed on to consumers. This follows …

Continue reading »

Older posts «